Below are the most recent publications written about "Solubility" by people in Profiles.
-
Aare M, Padakanti SC, Singh M. In Vivo Pharmacodynamic and Pharmacokinetic Assessment of Cannabidiol-loaded Camel Milk Exosomes in Doxorubicin-resistant Triple-negative Breast Cancer Xenografts. AAPS PharmSciTech. 2025 Sep 11; 26(7):227.
-
Sutar Y, Adams JS, Wu X, Bhoyarekar V, Garcia Diaz M, Wallace J, Dave M, Zhang QY, Date AA. Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites. ACS Appl Mater Interfaces. 2025 Jun 04; 17(22):31954-31970.
-
Adams JS, Sutar Y, Mukkirwar S, Miglani C, Date AA. Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability. Mol Pharm. 2025 May 05; 22(5):2568-2580.
-
Banik SP, Kumar P, Basak P, Goel A, Ohia SE, Bagchi M, Chakraborty S, Kundu A, Bagchi D. A critical insight into the physicochemical stability of macular carotenoids with respect to their industrial production, safety profile, targeted tissue delivery, and bioavailability. Toxicol Mech Methods. 2025 Mar; 35(3):215-229.
-
Borchardt-Setter KA, Yu J, Stelzer T, Yu L. Surface Enrichment and Depletion of Components in a Ternary Drug-Surfactant-Polymer Amorphous Solid Dispersion. Mol Pharm. 2024 Aug 05; 21(8):4074-4081.
-
Hern?ndez Espinell JR, Toro V, Yao X, Yu L, Lop?z-Mej?as V, Stelzer T. Solvent-Mediated Polymorphic Transformations in Molten Polymers: The Account of Acetaminophen. Mol Pharm. 2022 07 04; 19(7):2183-2190.
-
Yao X, Benson EG, Gui Y, Stelzer T, Zhang GGZ, Yu L. Surfactants Accelerate Crystallization of Amorphous Nifedipine by Similar Enhancement of Nucleation and Growth Independent of Hydrophilic-Lipophilic Balance. Mol Pharm. 2022 07 04; 19(7):2343-2350.
-
Sutar Y, Fulton SR, Paul S, Altamirano S, Mhatre S, Saeed H, Patel P, Mallick S, Bhat R, Patravale VB, Chauhan H, Nielsen K, Date AA. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS Infect Dis. 2021 09 10; 7(9):2637-2649.
-
Gao S, Siddiqui N, Etim I, Du T, Zhang Y, Liang D. Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms. Biomed Pharmacother. 2021 Oct; 142:112080.
-
Gupta R, Chen Y, Xie H. In vitro dissolution considerations associated with nano drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 11; 13(6):e1732.